Aiko Oka

Dr. Aiko Oka

International University of health and Welfare
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
NINaruhito Iwasaki
Naruhito Iwasaki
JPJulie A. Poposki
Julie A. Poposki
AOAiko Oka
Aiko Oka
MKMasanori Kidoguchi
Masanori Kidoguchi
AKAiko I. Klingler
Aiko I. Klingler
AKAtsushi Kato
Atsushi Kato

1 January 2025 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
MOMitsu Okano
Mitsu Okano
MYMarie Yamada
Marie Yamada
AOAiko Oka
Aiko Oka
Okano M, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):8-21. https://doi.org/10.4168/aair.2025.17.1.8

21 June 2025 in Auris Nasus Larynx
Verified
Journal Article
Closed access
MOMitsu Okano
Mitsu Okano
KOKimihiro Okubo
Kimihiro Okubo
MGMinoru Gotoh
Minoru Gotoh
MAMikiya Asako
Mikiya Asako
NONobuo Ohta
Nobuo Ohta
TYTomokazu Yoshizaki
Tomokazu Yoshizaki

22 September 2023 in Auris Nasus Larynx
Verified
Journal Article
Closed access
MOMitsu Okano
Mitsu Okano
KKKengo Kanai
Kengo Kanai
AOAiko Oka
Aiko Oka

21 October 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
AOAiko Oka
Aiko Oka
MOMitsu Okano
Mitsu Okano
The demand for allergen specific immunotherapy (AIT), especially sublingual immunotherapy (SLIT), is increasing because of its efficacy in inducing clinical remission of allergic diseases and its low risk of side effects. Since not all patients that undergo SLIT demonstrate an improvement in allergic symptoms, the development of biomarkers to predict the outcome and adjuvants for SLIT is desired. Saliva is the first target with which tablets used in SLIT come into contact, and salivary pH, chemical properties or microbiome composition are reported to possibly be associated with the outcome of SLIT. Antibodies such as IgG4 and IgA not only in the serum but also in the saliva are increased after SLIT and may also be associated with the efficacy of SLIT. The development of the metagenomic sequencing technique makes it possible to determine the microbiome composition and ratio of each bacterium, and researchers can investigate the relationships between specific bacteria and the immune response. Some bacteria are reported to improve the SLIT outcome and have the potential to be used as biomarkers for the selection of patients and as adjuvants in SLIT. Here, we introduce biomarkers for SLIT and present recent findings regarding the relationship between saliva and SLIT.

1 September 2013 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
TMTakanobu Mashiko
Takanobu Mashiko
FOFumio Ohnishi
Fumio Ohnishi
AOAiko Oka
Aiko Oka
TKTsukasa Kawauchi
Tsukasa Kawauchi
ISIchiro Shiokawa
Ichiro Shiokawa
TMToshiharu Minabe
Toshiharu Minabe